In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  calcitriol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MEC 10-2-088, NCT01358045

2.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 05M1, P30CA060553, NU-0310-093, SPRI-NU-05M1, NCT00301067

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: UMCC 2008.042, HUM 21242, NCT00794547

4.

Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PCI-9304, NCI-V93-0286

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000270758, RPCI-RP-0203, PCI-00-034, NCT00054522

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: UPCI 01-020, FD-R-002025-01, NCT00030069

8.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 011-017, NCT00536770

9.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RSRB00025478, NCT00904033

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000445077, OHSU-GIM-02007-L, OHSU-1104, NCT00238199

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068720, OHSU-6218, OHSU-HOR-00059-L, NCI-G01-1963, NCT00017576

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 100
Sponsor: NCI, Other
Protocol IDs: CDR0000441172, OHSU-8451, OHSU-VA-IRB-9451, NCT00182741

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000067041, OHSU-5231, OCC-HOR-98068-L, NCI-V99-1542, NCT00004043

14.

Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 to 88
Sponsor: Other
Protocol IDs: 25741, NCT01293682

15.

Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: OHSU-4673, OCC-ONC-97079-L, NCI-V98-1381

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-99073, NCI-H00-0048, NCT00004928

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 97-004, CDR0000068374, PCI-IRB-970532, NCI-G00-1885, PCI-97-004, NCT00008086

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 98-019, CDR0000068411, PCI-IRB-980542, NCI-G00-1901, PCI-98019, NCT00009802

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PCI-99044, CDR0000068457, PCI-IRB-990606, NCT00010231

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000365546, RPCI-RPC-0207, ZENECA-1839US/0295, NCT00084708

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: I 33204, RPCI-I-33204, NCT00238225

22.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 45 and over
Sponsor: Other
Protocol IDs: PROS0022, 97408, NCT00482157

23.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 40 to 70
Sponsor: Other
Protocol IDs: FMUSPIBCCVD2009, CAPPesq 626/06, FAPESP 07/04799-2, IBCC 108/2006/07, CAPPesq 0018/09, NCT00926315
New Search